mesalamine has been researched along with Endocarditis, Loeffler in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Usta, Y | 1 |
Ozen, H | 1 |
Gurakan, F | 1 |
Uslu, N | 1 |
Saltik-Temizel, IN | 1 |
Demir, H | 1 |
Yuce, A | 1 |
Tanaka, H | 1 |
Katoh, D | 1 |
Shimizu, M | 1 |
Ohno, T | 1 |
Tanaka, S | 1 |
Kanda, Y | 1 |
2 other studies available for mesalamine and Endocarditis, Loeffler
Article | Year |
---|---|
Hypereosinophilia due to mesalazine treatment.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Humans; Hypereosinophilic Syndrome; Inflammatory Bow | 2009 |
[A case of neonatal severe hypereosinophilia associated with mesalazine administered during pregnancy].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Hypereosinophilic Synd | 2002 |